Clinical Trials at the Summit: Healio’s latest videos
Click Here to Manage Email Alerts
Need to catch up on anything from this year’s Clinical Trials at the Summit? Here are some of Healio’s latest videos from the meeting.
Hot topics include gene therapy for geographic atrophy, the first-in-human trials of RO-104 and post-marketing safety data for Izervay.
VIDEO: Trispecific antibody has multiple targets in refractory diabetic macular edema
Charles Semba, MD, chief medical officer of Eluminex Biosciences, discusses a trispecific antibody for refractory diabetic macular edema. Watch here.
VIDEO: Gene therapy candidate may reduce treatment burden in neovascular AMD Adam Turpcu, PhD, of Adverum Biotechnologies discusses Ixo-vec for neovascular age-related macular degeneration. Watch here.
VIDEO: Astellas offers updates on Izervay safety, phase 1 geographic atrophy trial Carolyn Sasse provides updates about post-marketing safety data for Izervay and a phase 1 trial that is currently recruiting patients with geographic atrophy secondary to age-related macular degeneration. Watch here.
VIDEO: RevOpsis prepares for first-in-human trials of RO-104
Ramanath Bhandari, MD, FASRS, of RevOpsis Therapeutics discusses the development of RO-104 for the treatment of retinal disease. Watch here.
VIDEO: Kriya reviews geographic atrophy, thyroid eye disease gene therapies
Shankar Ramaswamy, MD, of Kriya Therapeutics highlights the company’s gene therapy programs for geographic atrophy and thyroid eye disease. Watch here.
Collapse
Healio Coverage
Click Here to Manage Email Alerts